Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2562 to 2611 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2562\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cgthba protein (-14 gene protein). [source:swissprot;acc:q12980]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5291.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5187.78\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02002\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2563\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hiv tat specific factor 1; cofactor required for tat activation of hiv-1 transcription. [source:refseq;acc:nm\_014500]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2564\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-cell leukemia homeobox protein 3 (homeobox protein hox-11l2). [source:swissprot;acc:o43711]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3964.71\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4042.75\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01968\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2565\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein barh-like 1. [source:swissprot;acc:q9hbu1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2566\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
opsin 4 (melanopsin). [source:swissprot;acc:q9uhm6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2567\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-cell leukemia homeobox protein 2 (homeobox protein hox-11l1) (neural crest homeobox protein). [source:swissprot;acc:o43763]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2568\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-cell leukemia homeobox protein 1 (homeobox protein hox-11) (tcl-3 proto-oncogene). [source:swissprot;acc:p31314]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2569\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hect domain containing protein 1 (fragment). [source:swissprot;acc:q9ult8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2570\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein barh-like 2. [source:swissprot;acc:q9umq3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2571\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kruppel-related zinc finger protein hckrox. [source:refseq;acc:nm\_015872]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7056.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7194.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01963\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2572\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 288 (dendritic-derived btb/poz zinc finger protein). [source:swissprot;acc:q9hc78]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7056.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7194.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01962\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2573\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal targeting signal 2 receptor (pts2 receptor) (peroxin-7). [source:swissprot;acc:o00628]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7056.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7194.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01961\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2574\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
katanin p60 subunit a 1. [source:refseq;acc:nm\_007044]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4327.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4248.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01863\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2575\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho interacting protein 3. [source:refseq;acc:nm\_015134]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5608.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5712.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01858\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2576\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein tara (trio-associated repeat on actin) (hrihfb2122). [source:swissprot;acc:q9h2d6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5608.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5712.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01857\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2577\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translin. [source:swissprot;acc:q15631]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4979.44\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5071.53\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01849\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2578\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translin-associated protein x (translin-associated factor x). [source:swissprot;acc:q99598]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2579\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyglutamine binding protein 1; nuclear protein containing ww domain 38 kd. [source:refseq;acc:nm\_005710]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2580\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
katanin p80 subunit b 1; katanin (80 kda); katanin p80 (wd40-containing) subunit b 1. [source:refseq;acc:nm\_005886]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4331.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4252.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01848\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2581\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 19 kda polypeptide (ec 2.7.7.6) (rpb7). [source:swissprot;acc:p52433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4570.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4654.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01841\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2582\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 23 kda polypeptide (ec 2.7.7.6) (rpb25) (xap4) (rpb5) (rpabc1). [source:swissprot;acc:p19388]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3899.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3829.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01821\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2583\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polymerase (rna) iii (dna directed) (32kd). [source:refseq;acc:nm\_006467]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3926.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3857.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01776\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2584\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deformed epidermal autoregulatory factor 1 homolog (nuclear deaf-1 related transcriptional regulator) (nudr) (suppressin) (zinc finger mynd domain containing protein 5). [source:swissprot;acc:o75398]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4180.32\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4253.46\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0175\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2585\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rio kinase 1 isoform 1; ad034 protein. [source:refseq;acc:nm\_031480]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2586\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
map/microtubule affinity-regulating kinase 1. [source:refseq;acc:nm\_018650]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2587\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
map/microtubule affinity-regulating kinase 2 isoform b; elkl motif kinase 1; elkl motif kinase. [source:refseq;acc:nm\_004954]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2588\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
meiotic recombination protein spo11. [source:swissprot;acc:q9y5k1]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2589\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7181.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7057.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01747\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2590\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromobox protein homolog 5 (heterochromatin protein 1 homolog alpha) (hp1 alpha) (antigen p25). [source:swissprot;acc:p45973]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7551.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7422.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01741\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2591\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromobox protein homolog 3 (heterochromatin protein 1 homolog gamma) (hp1 gamma) (modifier 2 protein) (hech). [source:swissprot;acc:q13185]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7550.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7422.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01726\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2592\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translationally controlled tumor protein (tctp) (p23) (histamine- releasing factor) (hrf). [source:swissprot;acc:p13693]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7169.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7047.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01717\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2593\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp41 (ec 3.1.13.-) (ribosomal rna processing protein 41) (p12a). [source:swissprot;acc:q9npd3]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4921.84\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5005.06\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01691\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2594\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp4 (ec 3.1.13.-) (ribosomal rna processing protein 4). [source:swissprot;acc:q13868]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2595\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp40 (ec 3.1.13.-) (ribosomal rna processing protein 40) (p10) (cgi-102). [source:swissprot;acc:q9nqt5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2596\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp46 (ec 3.1.13.-) (ribosomal rna processing protein 46) (p12b) (chronic myelogenous leukemia tumor antigen 28). [source:swissprot;acc:q9nqt4]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2597\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2-17 kda 2 (ec 6.3.2.19) (ubiquitin- protein ligase) (ubiquitin carrier protein) (e2(17)kb 2). [source:swissprot;acc:p51669]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8104.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7970.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01689\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2598\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromobox protein homolog 1 (heterochromatin protein 1 homolog beta) (hp1 beta) (modifier 1 protein) (m31) (heterochromatin protein p25). [source:swissprot;acc:p23197]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7538.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7417.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0163\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2599\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alanyl-trna synthetase (ec 6.1.1.7) (alanine--trna ligase) (alars). [source:swissprot;acc:p49588]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4367.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4438.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01627\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrolipoamide dehydrogenase, mitochondrial precursor (ec 1.8.1.4) (glycine cleavage system l protein). [source:swissprot;acc:p09622]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6185\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6283.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01597\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2601\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad50 homolog isoform 1. [source:refseq;acc:nm\_005732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7222.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7110.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01566\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2602\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim/homeobox protein lhx3. [source:swissprot;acc:q9ubr4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7571.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7688.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01541\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2603\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim domain binding 2; lim binding domain 2; lim domain-binding factor-2. [source:refseq;acc:nm\_001290]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7572.69\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7689.04\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01536\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2604\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim domain binding 1; carboxy terminal lim domain protein 2; lim domain-binding factor-1. [source:refseq;acc:nm\_003893]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7572.7\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2605\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim/homeobox protein lhx4. [source:swissprot;acc:q969g2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7573.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7689.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01531\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2606\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosyl-trna synthetase (ec 6.1.1.1) (tyrosyl--trna ligase) (tyrrs). [source:swissprot;acc:p54577]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4450.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4517.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01499\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2607\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stromal interaction molecule 1 precursor. [source:swissprot;acc:q13586]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.19\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01498\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2608\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trap/mediator complex component trap25. [source:refseq;acc:nm\_080651]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.18\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2609\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd repeat- and fyve domain-containing protein 2; wd40 and fyve domain containing 2. [source:refseq;acc:nm\_052950]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.41\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2610\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 4 (ec 2.7.1.-) (p21-activated kinase 4) (pak-4). [source:swissprot;acc:o96013]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.19\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2611\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyposis locus protein 1 (tb2 protein). [source:swissprot;acc:q00765]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.18\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/